Home-based pulmonary rehabilitation early after hospitalisation in COPD: A randomised controlled trial
Rationale COPD is characterised by respiratory exacerbations, often requiring hospitalisation. Post-hospitalisation pulmonary rehabilitation (PR) can reduce risk of readmission, but very few people attend PR post exacerbation. Objective To compare hospital readmission rates between people with COPD who undertake a home-based PR program commenced early (≤2 weeks) after hospital discharge (ePR) with usual care. Methods Assessor blinded, multi-centre RCT. Participants randomised 1:1 to ePR or usual care. ePR was 8 weeks (1 physiotherapy home-visit, plus 7x weekly phone calls). The primary outcome was all-cause, non-elective hospitalisation at 12 months after rehabilitation completion. Results From Jan 2020-Jun 2024 157 participants were randomised to ePR (n=77) or usual care (n=80). The ITT analysis included 151 participants (n=73 ePR, n=78 usual care; n=6 excluded: n=5 deceased, n=1 transplant). Rate of all-cause non-elective hospitalisation was not different between groups at 12-month follow-up (ePR 60.3%, usual care 64.1%; RR 0.94 [95%CI 0.73, 1.21]). There was no difference between groups for improvements in quality of life and breathlessness at either time point. There was a clinically and statistically significant reduction in anxiety favouring ePR (10-weeks post-discharge MD −2.1 [95%CI −3.4, −0.8]; 12-months MD −1.6 [95%CI −3.0, −0.2]). ePR completion rate (≥70% sessions) was high (n=57, 74%). When compared to no rehabilitation (per protocol), ePR completers demonstrated significant improvements in breathlessness, quality of life, anxiety/depression and self-efficacy. There was one intervention-related adverse event. Conclusion ePR delivered directly to patients in their homes, commenced within 2 weeks of hospital discharge, did not reduce hospital readmissions over 12 months compared to usual care but did support high program completion. When compared to no rehabilitation, improved clinical outcomes favoured ePR in those who completed the program.
Authors
- Anne Elizabeth Holland (ORCID: https://orcid.org/0000-0003-2061-845X)
- Ajay Singh Mahal (ORCID: https://orcid.org/0000-0002-7246-3261)
- Graham Hepworth (ORCID: https://orcid.org/0000-0003-3061-7186)
- Joanna Melinz
- Anthony K. May (ORCID: https://orcid.org/0000-0002-4028-949X)
- Renae J. McNamara (ORCID: https://orcid.org/0000-0001-5468-7176)
- Narelle S. Cox (ORCID: https://orcid.org/0000-0002-6977-1028)
- Aroub Lahham (ORCID: https://orcid.org/0000-0003-2090-0746)
- Janet Bondarenko (ORCID: https://orcid.org/0000-0002-2332-4417)
- Hayley Crute
- Angela T. Burge (ORCID: https://orcid.org/0000-0001-5455-6467)
- Lissa Spencer (ORCID: https://orcid.org/0000-0002-2358-0736)
- Christine Faye McDonald (ORCID: https://orcid.org/0000-0001-6481-3391)
- Paul O’Halloran (ORCID: https://orcid.org/0000-0001-6495-2359)
- Sarah L. Rawlings (ORCID: https://orcid.org/0009-0004-6967-5425)
- Samantha Gavin
- Melissa Elliott
Institutions
- The University of Melbourne (AU)
- La Trobe University (AU)
- Royal Prince Alfred Hospital (AU)
- Institute for Breathing and Sleep (AU)
- Prince of Wales Hospital (AU)
- Sydney Local Health District (AU)
- South Eastern Sydney Local Health District (AU)
- Monash University (AU)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1183/13993003.00985-2026
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00